[HTML][HTML] The impact of hypoxia on tumor-mediated bypassing anti-PD-(L) 1 therapy
K Mortezaee, J Majidpoor, E Kharazinejad - Biomedicine & …, 2023 - Elsevier
Extending the durability of response is the current focus in cancer immunotherapy with
immune checkpoint inhibitors (ICIs). However, factors like non-immunogenic tumor …
immune checkpoint inhibitors (ICIs). However, factors like non-immunogenic tumor …
Mdact: A new principle of adjunctive cancer treatment using combinations of multiple repurposed drugs, with an example regimen
Simple Summary We present eight core attributes of cancer growth that we must address for
a more effective treatment than we currently have. To do this we outline why a regimen …
a more effective treatment than we currently have. To do this we outline why a regimen …
Predicting non-small cell lung cancer-related genes by a new network-based machine learning method
Y Cai, Q Wu, Y Chen, Y Liu, J Wang - Frontiers in Oncology, 2022 - frontiersin.org
Lung cancer is the leading cause of cancer death globally, killing 1.8 million people yearly.
Over 85% of lung cancer cases are non-small cell lung cancer (NSCLC). Lung cancer …
Over 85% of lung cancer cases are non-small cell lung cancer (NSCLC). Lung cancer …